To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The exposome metabolome in paediatric inflammatory bowel disease: A cross-sectional study in a population-based Norwegian cohort
Örebro University, School of Medical Sciences.ORCID iD: 0009-0002-8951-9839
Örebro University, School of Medical Sciences.ORCID iD: 0000-0001-5752-4196
Oslo University Hospital, Department of Gastroenterology, Oslo, Norway; University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
Vestfold Hospital Trust, Department of Pediatrics, Tønsberg, Norway.
Show others and affiliations
2026 (English)In: Journal of Crohn's & Colitis, ISSN 1873-9946, E-ISSN 1876-4479, Vol. 20, no Suppl. 1, p. i603-i605, article id jjaf231269Article in journal, Meeting abstract (Other academic) Published
Abstract [en]

Background: Paediatric inflammatory bowel disease (IBD), comprising the subtypes Crohn’s disease (CD) and ulcerative colitis (UC), is believed to result from an interplay between genetic predisposition and environmental exposures. Examining exposome metabolome may help to identify environmental exposures, including host-derived metabolites, with potential relevance in paediatric IBD.

Methods: Relative concentrations of metabolites were measured in serum samples from treatment-naïve patients with IBD (N = 80) and symptomatic, non-IBD controls (N = 37) included in the IBSENIII cohort (Table 1). Ultra-high-performance liquid chromatography–mass spectrometry (UHPLC-MS) was performed. Authentic standards or the Human Metabolome Database were used for annotation. Associations with IBD, with CD (N = 53), and with UC including IBD-unclassified (N = 27), were assessed using logistic regression while adjusting for sex, age, and BMI. In addition, correlations with serum proteins (proximity extension assay technology) were examined. A false discovery rate (PFDR) threshold of < 0.1 was applied.

Results: We observed positive association of aryl sulfate (phenol sulfate; PFDR=0.03) with IBD versus symptomatic controls (Figure 1). Within the IBD population, aryl sulfate was positively correlated with several serum proteins, including CCL20 (r = 0.48, PFDR=0.004), MCP-3 (r = 0.47, PFDR=0.004), and TNF-α (r = 0.45, PFDR=0.001). We observed inverse associations of four perfluoroalkyl substances (PFAS); (linear-perfluorooctane sulfonate (PFOS-L), branched-perfluorohexanesulfonate (PFHxS-B), perfluorooctanoate (PFOA), and branched-perfluorooctane sulfonate (PFOS-B)) with IBD, UC, or both. In IBD, PFOA, PFOS-L, PFHxS-B positively correlated with Delta/Notch-like epidermal growth factor (EGF)-related receptor (DNER) protein levels. The secondary bile acid 6-ketholithocholic acid was inversely associated with UC, while the primary bile acids glycochenodeoxycholic acid-3-O-sulfate, cholic acid and glycocholic acid were positively associated with UC (all PFDR<0.1).

Conclusion: Several metabolites including aryl sulfate were associated with paediatric IBD and correlated with inflammation-related proteins. These findings confirm recent results from preclinical Crohn’s disease1 and may point towards a role of aryl sulfate at IBD diagnosis.

Place, publisher, year, edition, pages
Oxford University Press, 2026. Vol. 20, no Suppl. 1, p. i603-i605, article id jjaf231269
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-126818DOI: 10.1093/ecco-jcc/jjaf231.269ISI: 001666303100001OAI: oai:DiVA.org:oru-126818DiVA, id: diva2:2036740
Conference
21st Congress of ECCO, Stockholm, Sweden, February 18-21, 2026
Available from: 2026-02-09 Created: 2026-02-09 Last updated: 2026-02-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records

Salomon, BenitaSalihovic, SamiraGrännö, OlleBergemalm, DanielKruse, RobertRepsilber, DirkOresic, MatejHyötyläinen, TuuliaHalfvarson, Jonas

Search in DiVA

By author/editor
Salomon, BenitaSalihovic, SamiraGrännö, OlleBergemalm, DanielKruse, RobertRepsilber, DirkOresic, MatejHyötyläinen, TuuliaHalfvarson, Jonas
By organisation
School of Medical SciencesÖrebro University HospitalSchool of Science and Technology
In the same journal
Journal of Crohn's & Colitis
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 27 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf